Annual Review Course Webcast (2016): Infertility

In preparation for the American Board of Urology (ABU) Qualifying (Part 1) Examination, residents need to have basic urologic knowledge to prepare them for the ABU examinations. To fulfill this need, the American Urological Association (AUA) developed this course to disseminate current urologic knowledge. This course may also be of interest to practicing urologist preparing for the Recertification Examination as well as others, including allied health professionals, looking for a thorough review of basic urologic topics.

Learning Objectives

  1. Physiology and Pathophysiology of Male Reproduction
  2. Evaluation of the Infertile Male
  3. Treatment of the Infertile Male (Surgical and Non-surgical)
  4. Hypogonadism
  5. Testosterone Replacement
Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Non-Physician Participation
Course opens: 
06/25/2016
Course expires: 
06/25/2019
Rating: 
0

Faculty Disclosures

NameCompanyPersonRoleFinancial
Jay Todd Bishoff, MD, FACSPfizerSelfScientific Study or TrialYes
Myriad GeneticsSelfConsultant or Advisor, Scientific Study or TrialYes
Howard B. Goldman, MD, FACSJohnson and JohnsonSelfConsultant or Advisor, Meeting Participant or LecturerYes
American Medical SystemsSelfConsultant or AdvisorYes
watsonSelfMeeting Participant or LecturerYes
allerganSelfMeeting Participant or LecturerYes
johnson and johnsonSelfMeeting Participant or LecturerYes
pfizerSelfConsultant or Advisor, Meeting Participant or LecturerYes
TheracoatSelfConsultant or AdvisorYes
WellspectSelfConsultant or AdvisorYes
CookSelfScientific Study or TrialNo
american medical systemsSelfConsultant or Advisor, Meeting Participant or LecturerYes
pfizerSelfConsultant or Advisor, Meeting Participant or LecturerYes
axonicsSelfConsultant or AdvisorYes
astellasSelfMeeting Participant or LecturerYes
TevaSelfConsultant or AdvisorYes
TDocSelfConsultant or AdvisorYes
TevaSelfConsultant or AdvisorYes
MedtronicSelfConsultant or Advisor, Meeting Participant or Lecturer, Scientific Study or TrialYes
uroplastySelfConsultant or Advisor, Meeting Participant or LecturerYes
Brian Herts ,MDSiemens Medical SolutionsSelfScientific Study or TrialNo
Duane R. Hickling, MDAstellasSelfConsultant or Advisor, Meeting Participant or Lecturer, Scientific Study or TrialYes
PfizerSelfMeeting Participant or LecturerYes
AllerganSelfConsultant or Advisor, Meeting Participant or LecturerYes
Adam Stuart Kibel MDDendreonSelfConsultant or Advisor, Meeting Participant or LecturerYes
Sanofi-AventisSelfConsultant or Advisor, Scientific Study or TrialYes
National Cancer InstituteSelfConsultant or AdvisorYes
SpecrumSelfConsultant or AdvisorYes
Myriad GeneticsSelfConsultant or AdvisorYes
Genomic HealthSelfConsultant or AdvisorYes
MTGSelfConsultant or AdvisorYes
ProfoundSelfConsultant or AdvisorYes
DendreonSelfConsultant or AdvisorYes
Andrew Jared Kirsch MD    
Martin A. Koyle MD    
Stephen R. Kraus, MDNIDDKSelfScientific Study or TrialNo
LaborieSelfOtherYes
PfizerSelfConsultant or AdvisorYes
AllerganSelfConsultant or AdvisorYes
MerckSelfConsultant or AdvisorYes
AstellasSelfConsultant or Advisor, Meeting Participant or LecturerYes
MedtronicSelfMeeting Participant or LecturerYes
Seth Paul Lerner, MD, FACSImaluxSelfConsultant or Advisor, Scientific Study or TrialYes
TengionSelfConsultant or Advisor, Scientific Study or TrialYes
ImaluxSelfConsultant or Advisor, Scientific Study or TrialNo
Celek Pharmaceuticals, LLCSelfConsultant or Advisor, Scientific Study or TrialYes
Celek Pharmaceuticals, LLCSelfConsultant or Advisor, Scientific Study or TrialNo
GE HealthcareSelfConsultant or AdvisorYes
Taris BiomedicalSelfConsultant or AdvisorYes
ViventiaSelfScientific Study or TrialNo
VaxxionSelfConsultant or AdvisorYes
SitkaSelfConsultant or AdvisorYes
NucleixSelfConsultant or AdvisorYes
OncoGeneXSelfConsultant or AdvisorYes
MerckSelfConsultant or AdvisorYes
DendreonSelfScientific Study or TrialNo
PhotocureSelfConsultant or AdvisorYes
TarisSelfConsultant or AdvisorYes
FKDSelfScientific Study or TrialYes
TheracoatSelfConsultant or AdvisorNo
BiocancellSelfConsultant or AdvisorYes
GenentechSelfConsultant or AdvisorYes
Endo PharmaceuticalSelfScientific Study or TrialNo
CelgeneSelfScientific Study or TrialNo
CephalonSelfScientific Study or TrialNo
Astra ZenecaSelfMeeting Participant or LecturerYes
TengionSelfConsultant or Advisor, Scientific Study or TrialYes
DendreonSelfConsultant or AdvisorYes
Armando J. Lorenzo MDAllerganSelfConsultant or AdvisorYes
Allen F. Morey, MDAMSSelfMeeting Participant or LecturerYes
Glaxo Smith KlineSelfMeeting Participant or LecturerYes
PfizerSelfMeeting Participant or LecturerYes
ColoplastSelfMeeting Participant or LecturerYes
John Patrick Mulhall ,MDAuxiliumSelfConsultant or AdvisorYes
Association of Peyronie's Disease Advocates (APDA)SelfLeadership PositionNo
PfizerSelfConsultant or Advisor, Meeting Participant or Lecturer, Scientific Study or TrialNo
VivusSelfConsultant or Advisor, Scientific Study or TrialYes
NexmedSelfConsultant or AdvisorYes
Absorption PharmaceuticalsSelfConsultant or AdvisorYes
AMSSelfConsultant or Advisor, Scientific Study or TrialYes
MedaSelfConsultant or AdvisorYes
LillySelfConsultant or AdvisorYes
Alliance for Fertility PreservationSelfLeadership PositionNo
ColoplastSelfScientific Study or TrialYes
ColoplastSelfScientific Study or TrialYes
Michael A. O'Donnell, MDViventiaSelfConsultant or AdvisorYes
Spectrum PharmaceuticalsSelfConsultant or AdvisorYes
AmplimmuneSelfScientific Study or TrialYes
MerckSelfConsultant or AdvisorYes
PfizerSelfScientific Study or TrialYes
CytologicsSelfConsultant or AdvisorYes
Actium BiosystemsSelfConsultant or AdvisorYes
TelestaSelfConsultant or AdvisorYes
Roche/GenentechSelfScientific Study or TrialYes
Medical EnterprisesSelfConsultant or Advisor, Scientific Study or TrialYes
Medical EnterprisesSelfConsultant or AdvisorNo
Sanofi-AventisSelfConsultant or AdvisorYes
GE medicalSelfConsultant or AdvisorNo
PhotocureSelfScientific Study or TrialNo
AllerganSelfConsultant or AdvisorYes
Endo PharmaceuticalsSelfConsultant or AdvisorYes
Glenn M. Preminger, MDBoston ScientificSelfConsultant or AdvisorYes
Mission PharmacalSelfConsultant or AdvisorYes
OlympusSelfMeeting Participant or LecturerYes
Endourological SocietySelfLeadership PositionYes
UpToDateSelfHealth PublishingYes
RetrophinSelfConsultant or Advisor, Meeting Participant or LecturerYes
Peter Gerard Schulam, MD, PhDChironSelfOtherYes
OncuraSelfMeeting Participant or LecturerYes
ACMISelfOwner, Product DevelopmentYes
Intuitive SurgicalSelfInvestment InterestYes
Bard UrologicalSelfMeeting Participant or LecturerYes
SurgiquestSelfConsultant or AdvisorYes
HUMMSelfConsultant or AdvisorYes
Wade Jeffers Sexton, MD    
Daniel Arthur Shoskes MDTriurolSelfInvestment InterestNo
Farr LabsSelfConsultant or AdvisorYes
AstellasSelfConsultant or AdvisorYes
Eli LillySelfConsultant or AdvisorYes
UracystSelfConsultant or AdvisorYes
Pierre FabreSelfConsultant or AdvisorYes
Paul Jacob Turek, MDMandalMedSelfLeadership PositionYes
Medical Board of CaliforniaSelfConsultant or AdvisorYes
HealthLoop.comSelfConsultant or Advisor, Investment InterestYes
Doximity, IncSelfConsultant or Advisor, Investment InterestYes
Fertility Planit, IncSelfConsultant or Advisor, Investment InterestYes
Episona, IncSelfConsultant or AdvisorYes
Cellarity Biotechnologies, IncSelfLeadership Position, Investment Interest, Owner, Product DevelopmentYes
BioQuiddity, IncFamilyConsultant or Advisor, Investment InterestYes
Essential Beginnings, IncFamilyLeadership Position, Investment Interest, Owner, Product DevelopmentYes
Robert G. Uzzo, MD, FACSPfizerSelfMeeting Participant or LecturerYes
WilexSelfScientific Study or TrialYes
JanssenSelfMeeting Participant or LecturerYes
GSKSelfScientific Study or TrialYes
MyriadSelfConsultant or AdvisorYes
J. Christian Winters, MDAstellas, IncSelfConsultant or AdvisorYes
ConturaSelfScientific Study or TrialNo
PfizerSelfConsultant or AdvisorYes
Solace TheraSelfScientific Study or TrialNo
AllerganSelfConsultant or AdvisorYes
American Board of UrologySelfLeadership PositionNo
Society of Urodynamics, Female Pelvic Medicine and Urogential ReconstructionSelfLeadership PositionNo
FerringSelfConsultant or AdvisorYes
SolaceSelfScientific Study or TrialYes
StimGuardSelfConsultant or AdvisorYes

Education Council Disclosures

NameCompanyRoleFinancial
Timothy Charles Brand, M.D.

Nothing to disclose

Peter Robert Carroll MD,MPHNIHScientific Study or TrialYes
Department of DefenseScientific Study or TrialYes
Myriad GeneticsScientific Study or TrialNo
AUA UpdateLeadership PositionYes
Genomic HealthScientific Study or TrialNo
Sam S. Chang, M.D.astellasConsultant or AdvisorYes
NIHScientific Study or TrialYes
GLGConsultant or AdvisorYes
Shelby Englert

Nothing to disclose

Pat Fox Fulgham, MDUrology Clinics of North TexasInvestment InterestYes
Matthew Thomas Gettman, M.D.

Nothing to disclose

Christina Giffin

Nothing to disclose

Misop Han, M.D.

Nothing to disclose

William C. Hulbert Jr. MD

Nothing to disclose

Douglas A. Husmann MD

Nothing to disclose

Brant Inman, M.D., MS, FRCSCDendreonScientific Study or TrialNo
Abbott LaboratoriesScientific Study or TrialNo
Genentech IncScientific Study or TrialNo
Combat MedicalConsultant or AdvisorYes
Mark L. Jordan MD,FACS

Nothing to disclose

Louis Koncz ,PA-CAmerican Medical SystemsMeeting Participant or LecturerYes
Hari K. Koul PhDNovartis PharmaceuticalsConsultant or AdvisorYes
Urologic ResearchLeadership PositionNo
PLOS oneLeadership PositionNo
OMICS groupLeadership PositionNo
Open Access PublishingLeadership Position, Health PublishingYes
Martin A. Koyle MD

Nothing to disclose

Tracey Lynn Krupski, MDArgosScientific Study or TrialNo
NCI- RAZORScientific Study or TrialNo
John Stephen Lam MD

Nothing to disclose

Cheryl Taylore Lee, MDEndo PharmaceuticalsScientific Study or TrialYes
Gary Evan Lemack ,M.D.AstellasConsultant or Advisor, Meeting Participant or LecturerYes
AllerganConsultant or Advisor, Meeting Participant or LecturerYes
MedtronicConsultant or AdvisorYes
Yair Lotan ,M.D.abbottScientific Study or TrialNo
DanoneConsultant or Advisor, Scientific Study or TrialYes
CepheidScientific Study or TrialNo
Pacific EdgeScientific Study or TrialNo
FKDScientific Study or TrialNo
MDxHealthConsultant or AdvisorYes
biocancellScientific Study or TrialNo
Genomic HealthScientific Study or TrialNo
GenomeDx Biosciences IncScientific Study or TrialNo
photocureScientific Study or TrialNo
Jill A. Macoska PhD

Nothing to disclose

Manoj Monga, MDFortecOtherYes
endourology societyLeadership PositionNo
Victor William Nitti,MDAstellasHealth Publishing, Scientific Study or TrialNo
AllerganHealth Publishing, Scientific Study or TrialNo
Serenity PharmeuticalsInvestment InterestYes
Cook MyositeScientific Study or TrialNo
Christopher Porter, MDNothing to disclose.
Gail S. Prins PhD Nothing to disclose
Jay D. Raman, MDAmerican Kidney Stone ManagementInvestment InterestYes
Lee Richstone, MD

Nothing to disclose

Heather Schultz, NPSUNAMeeting Participant or LecturerYes
Karl-Dietrich Sievert, M.D., Ph.D.AMSMeeting Participant or LecturerYes
MedtronicsMeeting Participant or Lecturer, Scientific Study or TrialYes
AllergenConsultant or Advisor, Meeting Participant or Lecturer, Scientific Study or TrialYes
NeotractMeeting Participant or LecturerYes
Joseph A. Smith Jr.,M.D.

Nothing to disclose

Sean Patrick Stroup, MDIntuitive SurgicalMeeting Participant or LecturerYes
NeoTractMeeting Participant or LecturerYes
Edouard John Trabulsi, MDGenomeDxConsultant or AdvisorYes

Method of Participation
To claim CME credit/hours of participation for each webcast, the learner must complete to pre-test view the webcast, complete the posttest, passing with 80% accuracy and submit the evaluation.

Estimated time to complete this activity: 1.50 hours

Release Date: June, 2016
Expiration Date: June, 2019

Accreditation: The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation: The American Urological Association designates this enduring material for a maximum of 1.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Learners: The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 CreditTM.

Evidence Based Content: It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

AUA Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) participating in an educational activity provided by the AUA are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Resolution of Identified Conflict of Interest: All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

  • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup.
  • Limit content to evidence with no recommendations
  • Introduction of a debate format with an unbiased moderator (point-counterpoint)
  • Inclusion of moderated panel discussion
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
  • Divestiture of the relationship by faculty

Off-label or Unapproved Use of Drugs or Devices: It is the policy of the AUA to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Disclaimer: The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.

Reproduction Permission: Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association.

Available Credit

  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Non-Physician Participation

Accreditation Period

Course opens: 
06/25/2016
Course expires: 
06/25/2019
Please login or register to take this course.